Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $6.93 per share for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2024-08-08
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $7.63, a 5.57% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $8.08, a 21.02% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $10.23, a 20.78% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was $8.47, a 10.72% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $6.18, a 35.56% decline from fiscal 2022.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $9.59, a 15.96% increase from fiscal 2021.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $8.27, a 15.02% increase from fiscal 2020.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $7.19, a 51.05% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-06-30 | $6.93 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $7.63 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $6.18 10-K · filed 2024-03-21 | |||
| 2023-09-30 | $7.03 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $8.11 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | $8.08 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $9.59 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $9.20 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $9.81 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $10.23 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $8.27 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $8.22 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | $8.05 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $8.47 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | $7.19 10-K · filed 2022-03-17 | |||
| 2020-09-30 | $7.57 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $7.51 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $7.65 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $4.76 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $3.41 10-Q · filed 2019-11-15 | |||
| 2019-06-30 | $6.70 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $2.10 10-Q/A · filed 2020-05-08 | |||
| 2018-12-31 | $2.10 10-K · filed 2020-03-31 | |||
| 2018-09-30 | $5.62 10-Q/A · filed 2020-05-08 | |||
| 2018-06-30 | $6.55 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | $3.95 10-K · filed 2020-03-31 | |||
| 2017-09-30 | $4.99 10-Q · filed 2017-11-03 | |||
| 2017-06-30 | $4.84 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $8.45 10-Q · filed 2017-05-15 | |||
| 2016-12-31 | $3.69 10-K · filed 2019-03-14 | |||
| 2016-09-30 | $3.35 10-Q · filed 2016-10-27 | |||
| 2015-12-31 | $3.57 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |